Competing interests I declare that there are no conflicts of interest regarding the publication of this document
Retatrutide, known by its scientific designation LY3437943, is a novel peptide designed to target weight loss through three key pathways
you feel full sooner and for longer, and 2) a disruption of the dopamine receptor, meaning the good feeling of eating something that you enjoy is not as rewarding
Besides, exenatide-4 has been found to inhibit the survival, migration, proliferation, and invasion of glioma cells in a GLP-1R/SIRT3 pathway dependent manner (219)
Diabetic retinopathy in people with diabetes In semaglutide studies in diabetes, early worsening of diabetic retinopathy complications was observed, likely related to rapid glucose improvement rather than a direct drug effect
This extra metabolic effect is one reason retatrutide has shown such impressive weight loss results in early research